The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Abstract
Increased serum uric acid (SUA) levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension, gout, non-alcoholic fatty liver disease, chronic kidney disease (CKD), and cardiovascular diseases. Although some ambiguity for the exact role of uric acid (UA) in these diseases is still present, several pathophysiological mechanisms have been identified such as increased oxidative stress, inflammation, and apoptosis. Accumulating evidence in genomics enlightens genetic variabilities and some epigenetic changes that can contribute to hyperuricemia. Here we discuss the role of UA within metabolism and the consequences of asymptomatic hyperuricemia while providing newfound evidence for the associations between UA and gut microbiota and vitamin D. Increased SUA levels and beneficial effects of lowering SUA levels need to be elucidated more to understand its complicated function within different metabolic pathways and set optimal target levels for SUA for reducing risks for metabolic and cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
High Uric Acid Inhibits Cardiomyocyte Viability Through the ERK/P38 Pathway via Oxidative Stress
Li, Z., Shen, Y., Chen, Y., Zhang, G., Cheng, J., & Wang, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487356 · Cited by 60
RetractedTrained Immunity: A Memory for Innate Host Defense
Netea, M. G., Quintin, J., & van der Meer, J. W. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.04.006 · Cited by 1,682
Regulation of uric acid metabolism and excretion
Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., & Mollace, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.109 · Cited by 1,375
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Hyperuricemia induces endothelial dysfunction
Khosla, U. M., Zharikov, S., Finch, J. L., Nakagawa, T., Roncal, C., Mu, W., Krotova, K., Block, E. R., Prabhakar, S., & Johnson, R. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00273.x · Cited by 1,199
Uric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 972
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Chen, D., Frezza, M., Schmitt, S., Kanwar, J., & P. Dou, Q. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519752 · Cited by 795
Bruins, P., Velthuis, H. T., Yazdanbakhsh, A. P., Jansen, P. G. M., van Hardevelt, F. W. J., de Beaumont, E. M. F. H., Wildevuur, C. R. H., Eijsman, L., Trouwborst, A., & Hack, C. E. (1997) · Circulation · doi:10.1161/01.cir.96.10.3542 · Cited by 793
Sautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00600.2006 · Cited by 787
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., Shafiu, M., Sundaram, S., Le, M., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 760
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Yao, C., Veleva, T., Scott, L., Cao, S., Li, L., Chen, G., Jeyabal, P., Pan, X., Alsina, K. M., Abu-Taha, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035202 · Cited by 653
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Choi, H. K., Liu, S., & Curhan, G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20761 · Cited by 595
High plasma uric acid concentration: causes and consequences
de Oliveira, E. P., & Burini, R. C. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-12 · Cited by 501
Dobrev, D., Friedrich, A., Voigt, N., Jost, N., Wettwer, E., Christ, T., Knaut, M., & Ravens, U. (2005) · Circulation · doi:10.1161/circulationaha.105.575332 · Cited by 462
Uric acid in metabolic syndrome: From an innocent bystander to a central player
Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C., Lanaspa, M. A., Nakagawa, T., & Johnson, R. J. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.11.026 · Cited by 419
Self-citationWu, J., Wei, Z., Cheng, P., Qian, C., Xu, F., Yang, Y., Wang, A., Chen, W., Sun, Z., & Lu, Y. (2020) · Theranostics · doi:10.7150/thno.43528 · Cited by 393
Sánchez-Lozada, L. G., Lanaspa, M. A., Cristóbal-García, M., García-Arroyo, F., Soto, V., Cruz-Robles, D., Nakagawa, T., Yu, M. A., Kang, D.-H., & Johnson, R. J. (2012) · Nephron Experimental Nephrology · doi:10.1159/000345509 · Cited by 340
Weir, C. J., Muir, S. W., Walters, M. R., & Lees, K. R. (2003) · Stroke · doi:10.1161/01.str.0000081983.34771.d2 · Cited by 334
Wang, J., Chen, Y., Zhong, H., Chen, F., Regenstein, J., Hu, X., Cai, L., & Feng, F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1874287 · Cited by 317
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Kimura, Y., Tsukui, D., & Kono, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212394 · Cited by 309
Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
Wimalawansa, S. J. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.017 · Cited by 300
Crișan, T. O., Cleophas, M. C. P., Oosting, M., Lemmers, H., Toenhake-Dijkstra, H., Netea, M. G., Jansen, T. L., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206564 · Cited by 284
Choi, Y.-J., Shin, H.-S., Choi, H. S., Park, J.-W., Jo, I., Oh, E.-S., Lee, K.-Y., Lee, B.-H., Johnson, R. J., & Kang, D.-H. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.98 · Cited by 283
Virdis, A., Masi, S., Casiglia, E., Tikhonoff, V., Cicero, A. F. G., Ungar, A., Rivasi, G., Salvetti, M., Barbagallo, C. M., Bombelli, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13643 · Cited by 279
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.
Li, L., Zhang, Y., & Zeng, C. (2020) · PubMed Central · Cited by 201
Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice
Guo, Y., Yu, Y., Li, H., Ding, X., Li, X., Jing, X., Chen, J., Liu, G., Lin, Y., Jiang, C., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02414-x · Cited by 200
Uric Acid and Hypertension: An Update With Recommendations
Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Kelley, E. E., Nakagawa, T., Madero, M., Feig, D. I., Borghi, C., Piani, F., Cara-Fuentes, G., Bjornstad, P., et al. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa044 · Cited by 196
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez-Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 193
Place, R. F., Noonan, E. J., & Giardina, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.030 · Cited by 189
Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243634 · Cited by 187
Uric Acid as a Cause of the Metabolic Syndrome
King, C., Lanaspa, M. A., Jensen, T., Tolan, D. R., Sánchez-Lozada, L. G., & Johnson, R. J. (2018) · Contributions to Nephrology · doi:10.1159/000484283 · Cited by 187
Choi, H. K., & Ford, E. S. (2008) · Rheumatology · doi:10.1093/rheumatology/ken066 · Cited by 184
Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway
Cai, W., Duan, X.-M., Liu, Y., Yu, J., Tang, Y.-L., Liu, Z.-L., Jiang, S., Zhang, C.-P., Liu, J.-Y., & Xu, J.-X. (2017) · BioMed Research International · doi:10.1155/2017/4391920 · Cited by 178
Takir, M., Kostek, O., Ozkok, A., Elcioglu, O. C., Bakan, A., Erek, A., Mutlu, H. H., Telci, O., Semerci, A., Odabas, A. R., et al. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000242 · Cited by 174
Self-citationMacrophage receptors implicated in the “adaptive” form of innate immunity
Bowdish, D. M. E., Loffredo, M. S., Mukhopadhyay, S., Mantovani, A., & Gordon, S. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.09.002 · Cited by 169
McCormick, N., O’Connor, M. J., Yokose, C., Merriman, T. R., Mount, D. B., Leong, A., & Choi, H. K. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41779 · Cited by 168
Uric acid priming in human monocytes is driven by the AKT–PRAS40 autophagy pathway
Crişan, T. O., Cleophas, M. C. P., Novakovic, B., Erler, K., van de Veerdonk, F. L., Stunnenberg, H. G., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620910114 · Cited by 165
The Paradoxical Role of Uric Acid in Osteoporosis
Lin, K.-M., Lu, C.-L., Hung, K.-C., Wu, P.-C., Pan, C.-F., Wu, C.-J., Syu, R.-S., Chen, J.-S., Hsiao, P.-J., & Lu, K.-C. (2019) · Nutrients · doi:10.3390/nu11092111 · Cited by 160
XIAO, J., ZHANG, X.-L., FU, C., HAN, R., CHEN, W., LU, Y., & YE, Z. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2148 · Cited by 159
LI, P., ZHANG, L., ZHANG, M., ZHOU, C., & LIN, N. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2491 · Cited by 159
AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
Cordero, M. D., Williams, M. R., & Ryffel, B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.009 · Cited by 154
Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
Yu, Y., Liu, Q., Li, H., Wen, C., & He, Z. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02233 · Cited by 134
Liu, X., Lv, Q., Ren, H., Gao, L., Zhao, P., Yang, X., Yang, G., Xu, D., Wang, G., Yang, W. Q., et al. (2020) · PeerJ · doi:10.7717/peerj.8664 · Cited by 134
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
Zavaroni, I., Mazza, S., Fantuzzi, M., Dall’Aglio, E., Bonora, E., Delsignore, R., Passeri, M., & Reaven, G. M. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00700.x · Cited by 129
Amaro, S., Soy, D., Obach, V., Cervera, Á., Planas, A. M., & Chamorro, Á. (2007) · Stroke · doi:10.1161/strokeaha.106.480699 · Cited by 126
Role of PI3K in the Progression and Regression of Atherosclerosis
Zhao, Y., Qian, Y., Sun, Z., Shen, X., Cai, Y., Li, L., & Wang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632378 · Cited by 118
Hyperuricemia is associated with impaired intestinal permeability in mice
Xu, D., Lv, Q., Wang, X., Cui, X., Zhao, P., Yang, X., Liu, X., Yang, W. Q., Yang, G., Wang, G., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00151.2019 · Cited by 116
Hyperuricemia is an independent competing risk factor for atrial fibrillation
Kuwabara, M., Niwa, K., Nishihara, S., Nishi, Y., Takahashi, O., Kario, K., Yamamoto, K., Yamashita, T., & Hisatome, I. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.268 · Cited by 115
Insulin resistance surrogates predict hypertension plus hyperuricemia
Li, Y., You, A., Tomlinson, B., Yue, L., Zhao, K., Fan, H., & Zheng, L. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13573 · Cited by 115
Xiong, H., Du, W., Zhang, Y., Hong, J., Su, W., Tang, J. T., Wang, Y., Lu, R., & Fang, J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20777 · Cited by 111
Hyperuricemia Causes Pancreatic β-Cell Death and Dysfunction through NF-κB Signaling Pathway
Lü, J., Xing, J. H., Ding, Y., Shen, Y., Shi, X., Ren, W., Wan, M., Guo, J., Zheng, S., Liu, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078284 · Cited by 104
Papežíková, I., Pekarová, M., Kolářová, H., Klinke, A., Lau, D., Baldus, S. E., Lojek, A., & Kubala, L. (2012) · Free Radical Research · doi:10.3109/10715762.2012.747677 · Cited by 102
Sun, H., Pei, D., Lue, K., & Chen, Y.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143786 · Cited by 98
Chiba, T., Matsuo, H., Kawamura, Y., Nagamori, S., Nishiyama, T., Wei, L., Nakayama, A., Nakamura, T., Sakiyama, M., Takada, T., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38884 · Cited by 94
The effect of polymorphism of uric acid transporters on uric acid transport
Wang, Z., Cui, T., Ci, X., Zhao, F., Sun, Y., Li, Y., Liu, R., Wu, W., Yi, X., & Liu, C. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0546-7 · Cited by 89
Liu, P., Wang, H., Zhang, F., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.4310 · Cited by 87
Uric acid and cardiometabolic diseases
Lee, S. J., Oh, B. K., & Sung, K. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00146-y · Cited by 84
Bendíčková, K., Tidu, F., & Frič, J. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707698 · Cited by 71
Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Darmawan, G., Hamijoyo, L., & Hasan, I. (2017) · Acta medica Indonesiana · Cited by 66
Uric acid in CKD: has the jury come to the verdict?
Bonino, B., Leoncini, G., Russo, E., Pontremoli, R., & Viazzi, F. C. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00702-7 · Cited by 64
Maharani, N., Ting, Y., Cheng, J., Hasegawa, A., Kurata, Y., Li, P., Nakayama, Y., Ninomiya, H., Ikeda, N., Morikawa, K., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0416 · Cited by 63
Kırça, M., Oğuz, N., Çetin, A., Uzuner, F., & Yeşilkaya, A. (2016) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2016.1203941 · Cited by 62
Liu, J., & Lloyd, S. G. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.02.005 · Cited by 60
Urate-induced epigenetic modifications in myeloid cells
Badii, M. O., Gaal, O. I., Cleophas, M. C. P., Klück, V., Davar, R., Habibi, E., Keating, S. T., Novakovic, B., Helsen, M. M., Dalbeth, N., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02580-1 · Cited by 59
Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation
Li, S., Jin, C., Cui, L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012020 · Cited by 58
Wrigley, R., Phipps‐Green, A. J., Topless, R., Major, T. J., Cadzow, M. J., Riches, P. L., Tausche, A., Janssen, M., Joosten, L. A. B., Jansen, T., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2136-z · Cited by 57
Hyperuricemia and gout caused by missense mutation in d-lactate dehydrogenase
Drabkin, M., Yogev, Y., Zeller, L., Zarivach, R., Zalk, R., Halperin, D. S., Wormser, O., Gurevich, E., Landau, D., Kadir, R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129057 · Cited by 56
Effect of uric acid on mitochondrial function and oxidative stress in hepatocytes
Yang, Y., Zhou, Y., Cheng, S., Sun, J., Yao, H., & Ma, L. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15028644 · Cited by 50
The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study
Kuwabara, M., Hisatome, I., Niwa, K., Bjornstad, P., Roncal-Jiménez, C. A., Andrés-Hernando, A., Kanbay, M., Johnson, R. J., & Lanaspa, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040942 · Cited by 50
Self-citationAssociation Between Vitamin D and Uric Acid in Adults: A Systematic Review and Meta-Analysis
Isnuwardana, R., Bijukchhe, S. M., Thadanipon, K., Ingsathit, A., & Thakkinstian, A. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1240-5850 · Cited by 50
Wang, Z., Zhao, Y., Phipps‐Green, A. J., Liu‐Bryan, R., Čeponis, A., Boyle, D. L., Wang, J., Merriman, T. R., Wang, W., & Terkeltaub, R. A. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41173 · Cited by 48
Cleophas, M. C. P., Crișan, T. O., Klück, V., Hoogerbrugge, N., Netea-Maier, R. T., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1834-x · Cited by 47
Levy, M., Thaiss, C. A., & Elinav, E. (2015) · Nature Medicine · doi:10.1038/nm.3808 · Cited by 46
Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus
Zhang, W., Wang, T., Guo, R., Cui, W., Yu, W., Wang, Z., Jiang, Y., Jiang, M., Wang, X., Liu, C., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.761757 · Cited by 46
Yang, J., Kamide, K., Kokubo, Y., Takiuchi, S., Horio, T., Matayoshi, T., Yasuda, H., Miwa, Y., Yoshii, M., Yoshihara, F., et al. (2008) · Hypertension Research · doi:10.1291/hypres.31.931 · Cited by 45
Serum uric acid as a cardiovascular risk factor for heart disease
Alderman, M. H. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0036-4 · Cited by 44
CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population
Li, B., Chen, X., Jiang, Y., Yang, Y., Zhong, J. M., Zhou, C., Hu, H., & Duan, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.06.011 · Cited by 43
Chen, Y., Xia, Y., Han, X., Yang, Y., Yin, X., Qiu, J., Liu, H., Zhou, Y., & Liu, Y. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-019037 · Cited by 41
Yan, C., Xu, S., Zhang, J., Ju, J., Chen, Z., Wang, K., Li, J., & Xu, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.641513 · Cited by 41
Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels
Higashino, T., Morimoto, K., Nakaoka, H., Toyoda, Y., Kawamura, Y., Shimizu, S., Nakamura, T., Hosomichi, K., Nakayama, A., Ooyama, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216044 · Cited by 37
Effect of uric acid on liver injury during hemorrhagic shock☆
Tsukada, K., Hasegawa, T., Tsutsumi, S., Katoh, H., Kuwano, H., Miyazaki, T., & Yamamoto, Y. (2000) · Surgery · doi:10.1067/msy.2000.104486 · Cited by 35
Hypouricemia: what the practicing rheumatologist should know about this condition
Pineda, C., Soto-Fajardo, C., Mendoza, J., Gutiérrez, J., & Sandoval, H. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04788-8 · Cited by 33
Roman, Y. M. (2019) · Europe PMC (PubMed Central) · Cited by 33
Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels
Chaves, F. J., Corella, D., Blesa, S., Mansego, M. L., Marín-García, P., Portolés, O., Sorlí, J. V., González-Albert, V., Tormos, M. C., García-García, A.-B., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000239970.23723.38 · Cited by 31
The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review
Demiray, A., Afşar, B., Covic, A. C., Kuwabara, M., Ferro, C. J., Lanaspa, M. A., Johnson, R. J., & Kanbay, M. (2021) · Angiology · doi:10.1177/00033197211012546 · Cited by 31
Self-citationNFATc3 deficiency reduces the classical activation of adipose tissue macrophages
Hu, L., He, F., Huang, M., Peng, M., Zhou, Z., Liu, F., & Dai, Y. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0070 · Cited by 26
Kobylecki, C. J., Vedel‐Krogh, S., Afzal, S., Nielsen, S. F., & Nordestgaard, B. G. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210273 · Cited by 24
Ponvilawan, B., Charoenngam, N., & Ungprasert, P. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13740 · Cited by 23
Wu, B., Hao, Y., Shi, J. P., Geng, N., Li, T., Chen, Y., Sun, Z., Zheng, L., LI, H., Li, N., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4135 · Cited by 21
Saeed, A., Hoogerland, J. A., Wessel, H., Heegsma, J., Derks, T. G. J., van der Veer, E., Mithieux, G., Rajas, F., Oosterveer, M. H., & Faber, K. N. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz283 · Cited by 18
Ng, H., Leung, F., Kuo, W., Lee, W., & Lee, C. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13574 · Cited by 16
Ameliorative Effect of Allopurinol on Vascular Complications of Insulin Resistance
El‐Bassossy, H. M., Elberry, A. A., Azhar, A. S., Ghareib, S. A., & Alahdal, A. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/178540 · Cited by 14
NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property
Chae, C.-S., Kim, G.-C., Park, E. S., Lee, C., Verma, R. P., Cho, H., Jun, C., Yoo, Y. J., & Im, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700882 · Cited by 11
Cited by
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Metadata
- Authors
- Copur, S., Demiray, A., & Kanbay, M.
- Venue
- European Journal of Internal Medicine
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 103
- Pages
- 4-12
- ISSN
- 0953-6205 (ISSN-L)
- OpenAlex
- W4225260803
- Cited by
- 287
- References
- 95
- FWCI
- 30.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.